Does Medicaid cover Wegovy?
Jump to section
Each state decides. KFF counted 13 state Medicaid programs covering GLP-1s for obesity in January 2026, down from 16 in October 2025; Massachusetts then ended coverage on July 3, 2026, leaving 12 or fewer as of July 2026. Check your state's preferred drug list.
What Medicaid specifically requires
- California Medi-Cal: Wegovy removed from the drug list for weight loss on January 1, 2026; requests considered for MASH or cardiovascular disease
- Massachusetts MassHealth: weight-loss coverage ended July 3, 2026; still covered with prior authorization for established cardiovascular disease with BMI above 27, or MASH
- Members under 21: requests reviewed for medical necessity under the federal EPSDT benefit (California and Massachusetts)
Sources: KFF: Medicaid coverage of and spending on GLP-1s (Jan 16, 2026); MassHealth Pharmacy Facts #271: anti-obesity medications (Mar 12, 2026); Anthem Blue Cross (Medi-Cal): GLP-1 Coverage Considerations (Nov 14, 2025)
About Medicaid coverage
- KFF: 13 state Medicaid programs covered GLP-1s for obesity in fee-for-service as of January 2026, down from 16 in October 2025. California, New Hampshire, Pennsylvania and South Carolina ended coverage. KFF: Medicaid coverage of and spending on GLP-1s, Jan 16, 2026
- North Carolina ended Medicaid GLP-1 obesity coverage in October 2025 and reinstated it in December 2025. KFF: Medicaid coverage of and spending on GLP-1s, Jan 16, 2026
- MassHealth ended coverage of drugs used for weight loss, including Wegovy, Zepbound and Saxenda, on July 3, 2026. Coverage continues with prior authorization for cardiovascular disease, MASH and sleep apnea. MassHealth Pharmacy Facts #271: anti-obesity medications, Mar 12, 2026
- California Medi-Cal removed Wegovy, Zepbound and Saxenda from its drug list for weight loss on January 1, 2026; members under 21 are reviewed under EPSDT. Anthem Blue Cross (Medi-Cal): GLP-1 Coverage Considerations, Nov 14, 2025
- CMS announced the BALANCE model in December 2025, a voluntary program to negotiate lower GLP-1 prices for Medicaid and Medicare. KFF: Medicaid coverage of and spending on GLP-1s, Jan 16, 2026
Where to get Wegovy
Telehealth services that handle Wegovy, useful while prior auth processes or as a cash-pay alternative. We may earn a commission. See disclosure.
Ro
from $149/mo- Best for insured patients
- Best for clinical oversight
Ro Body, branded GLP-1 weight care program
Hims
from $149/mo- Best for cash-pay
- Best for speed
Hims Weight Loss, branded GLP-1 on a monthly membership
Medicaid not the right plan?
Coverage varies between carriers and even between plans at the same carrier. Compare GLP-1 coverage across 20 US insurers and programs, or run the insurance pre-check to estimate your specific plan's odds.
More Medicaid coverage
People also ask
Frequently asked
Does Medicaid cover Wegovy?+
Each state decides. KFF counted 13 state Medicaid programs covering GLP-1s for obesity in January 2026, down from 16 in October 2025; Massachusetts then ended coverage on July 3, 2026, leaving 12 or fewer as of July 2026. Check your state's preferred drug list.
Does Medicaid require prior authorization for Wegovy?+
Yes. Medicaid requires prior authorization for Wegovy. Your prescriber submits the request with the documentation listed in the Medicaid criteria on this page.